The subtype of Cupressaceae pollinosis associated with Pru p 7 sensitization is characterized by a sensitization to a cross‐reactive gibberellin‐regulated protein in cypress pollen: BP 14-Reference-Cited by-同舟云学术

The subtype of Cupressaceae pollinosis associated with Pru p 7 sensitization is characterized by a sensitization to a cross‐reactive gibberellin‐regulated protein in cypress pollen: BP 14

Published:2019-06-05 Issue: Volume: Page:
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Poncet Pascal¹²^ORCID,Aizawa Tomoyasu³^ORCID,Sénéchal Hélène²

Affiliation:

1. C2RT Institut Pasteur Paris France

2. Allergy & Environment Research Team, Biochemistry Department Armand Trousseau Children Hospital Paris France

3. Protein Science Laboratory Hokkaido University Sapporo Japan

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13418

Reference13 articles.

1. Pru p 7 sensitization is a predominant cause of severe, cypress pollen‐associated peach allergy

2. Cross-reactivity between cypress pollen and peach: a report of seven cases

3. IgE Reactivity to Common Cypress (C. Sempervirens) Pollen Extracts: Evidence for Novel Allergens

4. Les protéines régulées par la gibbérelline et l’énigme du « chaînon manquant »

5. Pollen/Fruit Syndrome: Clinical Relevance of the Cypress Pollen Allergenic Gibberellin-Regulated Protein

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of the diagnosis and characterization of gibberellin-regulated protein sensitization;Annals of Allergy, Asthma & Immunology;2024-01

2. Clinical relevance of gibberellin-regulated protein;Alergologia;2023-10-31

3. Cyclophilins and gibberellin-regulated proteins in IgE-mediated allergic diseases;Allergo Journal International;2023-10-04

4. The Role of Peamaclein (Pru p 7) in PFAS Patients: An Italian Real-Life Study;Allergies;2023-08-10

5. EAACIMolecular Allergology User's Guide 2.0;Pediatric Allergy and Immunology;2023-03